Compare, Analyse Unichem Lab with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   TEVA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
TEVA PHARMA
Dec-13
UNICHEM LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2922,980-   
Low Rs1822,589-   
Sales per share (Unadj.) Rs167.71,710.2-  
Earnings per share (Unadj.) Rs-3.6106.8-  
Cash flow per share (Unadj.) Rs5.9245.1-  
Dividends per share (Unadj.) Rs4.0093.52-  
Dividend yield (eoy) %1.73.4 50.2%  
Book value per share (Unadj.) Rs372.31,899.7-  
Shares outstanding (eoy) m70.38848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.41.6 86.8%   
Avg P/E ratio x-65.326.1 -250.5%  
P/CF ratio (eoy) x39.911.4 351.1%  
Price / Book Value ratio x0.61.5 43.4%  
Dividend payout %-110.287.5 -125.9%   
Avg Mkt Cap Rs m16,6802,361,010 0.7%   
No. of employees `0002.644.9 5.8%   
Total wages/salary Rs m2,3930-   
Avg. sales/employee Rs Th4,535.232,266.5 14.1%   
Avg. wages/employee Rs Th919.80-   
Avg. net profit/employee Rs Th-98.22,015.7 -4.9%   
INCOME DATA
Net Sales Rs m11,8011,450,216 0.8%  
Other income Rs m9840-   
Total revenues Rs m12,7851,450,216 0.9%   
Gross profit Rs m-835397,143 -0.2%  
Depreciation Rs m674117,222 0.6%   
Interest Rs m7528,485 0.3%   
Profit before tax Rs m-600251,436 -0.2%   
Minority Interest Rs m01,142 0.0%   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0-165,054 0.0%   
Tax Rs m-343-3,070 11.2%   
Profit after tax Rs m-25690,594 -0.3%  
Gross profit margin %-7.127.4 -25.8%  
Effective tax rate %57.3-1.2 -4,691.1%   
Net profit margin %-2.26.2 -34.7%  
BALANCE SHEET DATA
Current assets Rs m20,384979,471 2.1%   
Current liabilities Rs m5,029854,181 0.6%   
Net working cap to sales %130.18.6 1,506.1%  
Current ratio x4.11.1 353.5%  
Inventory Days Days10591 115.4%  
Debtors Days Days13596 140.6%  
Net fixed assets Rs m9,023473,673 1.9%   
Share capital Rs m1413,570 3.9%   
"Free" reserves Rs m26,0580-   
Net worth Rs m26,1991,610,915 1.6%   
Long term debt Rs m0741,528 0.0%   
Total assets Rs m31,4963,314,209 1.0%  
Interest coverage x-7.09.8 -71.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.40.4 85.6%   
Return on assets %-0.63.6 -15.9%  
Return on equity %-1.05.6 -17.3%  
Return on capital %-2.04.9 -40.5%  
Exports to sales %69.40-   
Imports to sales %00-   
Net fx Rs m7,5920-   
CASH FLOW
From Operations Rs m-3,278231,089 -1.4%  
From Investments Rs m-2,860-81,884 3.5%  
From Financial Activity Rs m-24-277,207 0.0%  
Net Cashflow Rs m-4,690-128,002 3.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare UNICHEM LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare UNICHEM LAB With: NOVARTIS  GSK PHARMA  DISHMAN PHARMA  ABBOTT INDIA  PLETHICO PHARMA  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views On News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Oct 17, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS